E2022 Patch Formulation Single Dose Phase I Study.
Phase of Trial: Phase I
Latest Information Update: 20 May 2016
At a glance
- Drugs Donepezil (Primary) ; Donepezil
- Indications Alzheimer's disease
- Focus Pharmacokinetics
- Sponsors Eisai Co Ltd
- 11 Aug 2011 Additional lead trial investigator (Tomoo Ogawa) identified as reported by ClinicalTrials.gov.
- 11 Aug 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 13 Dec 2010 New trial record